F. Laguia

Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

R. Rosell, M. Filipska, D. Lligé, 2020, Frontiers in Oncology.

Role of Siglecs in viral infections: A double-edged sword interaction

B. Clotet, J. Martinez-Picado, Patricia Resa-Infante, 2022, Molecular aspects of medicine.

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies

Peng Cao, Andrés Felipe Cardona, Andrés Aguilar, 2020, Cancers.

Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer

C. Alcon, F. Laguia, N. Jiménez, 2024, Frontiers in Pharmacology.